Literature DB >> 30968417

Scale-up of hepatitis C treatment in prisons is key to national elimination.

Timothy Papaluca1, Margaret E Hellard2, Alexander J V Thompson1, Andrew R Lloyd3.   

Abstract

Keywords:  Hepatitis C

Year:  2019        PMID： 30968417     DOI： 10.5694/mja2.50140

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  5 in total

1.  Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis.

Authors:  Jisoo A Kwon; Georgina M Chambers; Fabio Luciani; Lei Zhang; Shamin Kinathil; Dennis Kim; Hla-Hla Thein; Willings Botha; Sandra Thompson; Andrew Lloyd; Lorraine Yap; Richard T Gray; Tony Butler
Journal:  PLoS One       Date:  2021-02-11       Impact factor: 3.240

2.  Missed opportunities for hepatitis C treatment at a tertiary care hospital in South Australia.

Authors:  Sreecanth Sibhi Raja; Suzanne Edwards; Jeffrey Stewart; Dep Huynh
Journal:  World J Hepatol       Date:  2022-08-27

3.  Non-invasive fibrosis algorithms are clinically useful for excluding cirrhosis in prisoners living with hepatitis C.

Authors:  Timothy Papaluca; Anne Craigie; Lucy McDonald; Amy Edwards; Michael MacIsaac; Jacinta A Holmes; Matthew Jarman; Tanya Lee; Hannah Huang; Andrew Chan; Mark Lai; Vijaya Sundararajan; Joseph S Doyle; Margaret Hellard; Mark Stoove; Jessica Howell; Paul Desmond; David Iser; Alexander J Thompson
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240

4.  The hepatitis C virus care cascade in the New York City jail system during the direct acting antiviral treatment era, 2014-2017.

Authors:  Justin Chan; Fatos Kaba; Jessie Schwartz; Angelica Bocour; Matthew J Akiyama; Zachary Rosner; Ann Winters; Patricia Yang; Ross MacDonald
Journal:  EClinicalMedicine       Date:  2020-10-05

5.  The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience.

Authors:  Rebecca J Winter; Jacinta A Holmes; Timothy J Papaluca; Alexander J Thompson
Journal:  Viruses       Date:  2022-02-28       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.